News & Events | NuVasive

NuVasive’s Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement

March 16, 2021

NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies

February 24, 2021

NuVasive Acquires Simplify Medical

February 8, 2021

NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area

News

Filter Content

Refine

May 10, 2021

NuVasive Appoints Juliet C. Cunningham as Vice President of Investor Relations

May 5, 2021

NuVasive Announces First Quarter 2021 Financial Results

May 3, 2021

NuVasive to Present at Upcoming Investor Conferences

April 19, 2021

NuVasive Announces Conference Call and Webcast of First Quarter 2021 Results

April 6, 2021

NuVasive’s Simplify Disc Receives FDA Approval for Two-Level Cervical Total Disc Replacement

March 25, 2021

NuVasive Announces Retirement of Gregory T. Lucier from Board of Directors

March 16, 2021

NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies

February 25, 2021

NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results

February 24, 2021

NuVasive Acquires Simplify Medical

1
2
3
4
5
…
30
Next »

Upcoming Events

The materials on this website are for your general educational information only. Information you read on this website cannot replace the relationship that you have with your healthcare professional. We do not practice medicine or provide medical services or advice as a part of this website. You should always talk to your healthcare professional for diagnosis and treatment.